The result of this paper suggested that insulin therapy was harmful, especially in patients with low HbA1c levels or more severe forms of heart failure; therefore, specific management strategies and blood sugar targets may be needed when using insulin in patients with HF. This evidence concerns the gene INS and heart failure.